Trade Mark Journal No.2026/045 6 November 2026
WO0000001944735 (35,41,44,45)
Office of origin: Japan
Date of International Registration:17 June 2026
Date of designation in the UK:
17 June 2026
International priority date claimed: 28 May 2026
(Japan)
- Class 35
- Operation of businesses for others in the field of healthcare; healthcare operations management services, namely, connecting patients to qualified healthcare resources in the nature of administrative services relating to the referral of patients.
- Class 41
- Educational services, namely, organizing and conducting classes, seminars, conferences, symposiums and workshops in the health and medical field; educational services, namely, organizing and conducting classes, seminars, conferences, symposiums and workshops in the field of pharmaceutical, biomedical and biological therapeutic research; educational services, namely, organizing and conducting classes, seminars, conferences, symposiums and workshops for patients and their families and caregivers regarding the diagnosis, treatment and care of rare diseases and disorders and immunological diseases and disorders; healthcare education.
- Class 44
- Providing health information and medical information; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders and conditions; providing information to patients and their families and caregivers relating to the diagnosis, treatment and care of patients with rare diseases and disorders and immunological diseases and disorders; medication management and disease management being health care; patient advocacy services being advocacy services relating to health issues.
- Class 45
- Patient advocacy services being legal advocacy services; non-therapeutic customized support counseling for patients with congenital athymia; providing emotional support for patients and their families via interactive on-line forums; providing companionship services for families of patients with threatening disorders.
Sumitomo Pharma Co., Ltd.
Representative: SATO Shunji, TMI Associates,, 23rd Floor, Roppongi Hills Mori Tower,, 6-10-1 Roppongi, Minato-ku, Tokyo 106-6123, JAPAN